Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

NCT05991973 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

T Lymphoblastic Leukemia/Lymphoma

Interventions

DRUG: Chidamide

Sponsor

Zhejiang University

Collaborators

[object Object]
[object Object]